The Impact of Circulating Plasma Cells on Overall Survival (OS) in Patients with Newly Diagnosed Multiple Myeloma (MM) - Results of a Multicenter StudyM. I. Soloviev, Еlena Tarasenkо, Marina Savinova et al.|Blood|2024Cited by 1
Национальные клинические рекомендации по диагностике и лечению множественной миеломыЛ. П. Менделеева, Savchenko Vg, О. М. Вотякова et al.|Гематология и трансфузиология|2014Cited by 0
7+3+VP-16 as Remission Induction / Consolidation and Two Types of Maintenance in Adult AML: 8 Years Results of Russian Multicenter TrialSavchenko Vg, Н. В. Медведева, E. N. Parovitchnikova et al.|Hämatologie und Bluttransfusion|2003Cited by 0
Incidence and Prognostic Value of Bone and Extramedullary Plasmacytomas in Patients with Newly Diagnosed Multiple Myeloma: Data from a Prospective Population-Based StudyM. V. Solovev, M. N. Kozmina, Л. П. Менделеева et al.|Clinical oncohematology|2026Cited by 0